Review article · 9 Jun 2025
Conference abstractPublished 10 Aug 2015
Plant based analogues possessing selective toxicity against resistant colorectal cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Current modes of treatment, is less effective in aggressive colon cancer due to development of resistance, indicating novel targeted therapies for colon cancer are much needed. Harnessing beneficial effects of plant based molecules, we designed and developed molecules that retain the beneficial cytotoxic potential but have fewer side effects and can bypass drug resistance. We designed and synthesized severalnovel polycyclic heterocycles, with pyrimido[1,2:1,5]-pyrazolo[3,4-b]quinoline framework and evaluated them for anticancer activity against colon, breast, ovarian and hepatocellular carcinoma cell lines and non-cancer cells. The results of the screening studies revealed compound 5, a 4-chloro-2-methyl pyrimido[1”,2”:1,5]pyrazolo[3,4-b]quinoline to exhibit ten to fifteen times more selectivity and potent cytotoxic activity against seven colon cell lines at sub-nanomolar concentrations compared to other cell lines. This was also confirmed by changes in morphological status of the cells. Moreover, we found concentration dependent changes in mitochondrial membrane potential of HCT-116 with compound 5 leading to apoptosis and chromosomal DNA damage. Additionally, all the pyrimido[1,2:1,5]-pyrazolo[3,4-b]quinoline derivatives were found to-not-to be a substrate of MDR1/ABCB1/ P-glycoprotein and/or ABCG2 transporters. Gene-chip analysis revealed that Compound 5 produces significant change in key signaling pathways leading to cell survival and progression. In sum, this work has led to the discovery of a novel 4-chloro-2-methyl pyrimido[1”,2”:1,5]pyrazolo[3,4-b]quinoline with potent cytotoxic and apoptosis- inducing properties on colon cancer cells, without being a substrate of ABCB1 or ABCG2 drug resistance factors. More mechanistic and pharmacokinetic-pharmacodynamic [PKPD] directed studies integrated with rigorous toxicity studies would be conducted to bring Compound 5 or similar molecules in the clinics.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tiwari K Amit”
- BylineArticles whose byline prints “Karthikeyan Chandrabose”
- BylineArticles whose byline prints “Mittal Roopali”
- BylineArticles whose byline prints “Trivedi Piyush”
